speb/financial-data huggingface dataset:
MBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2952000.00
MBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -65066000.00
MBIO cash_flow (annual, 2022-12-31) — Change In Account Payable: 5300000.00
MBIO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -263000.00
MBIO cash_flow (annual, 2022-12-31) — Change In Payable: 5300000.00
MBIO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 5300000.00
MBIO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1006000.00
MBIO cash_flow (annual, 2022-12-31) — Change In Receivables: -1000.00
MBIO cash_flow (annual, 2022-12-31) — Change In Working Capital: 4030000.00
MBIO cash_flow (annual, 2022-12-31) — Changes In Cash: -33962000.00
MBIO balance_sheet (annual, 2022-12-31) — Common Stock: 11000.00
MBIO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 46273000.00
MBIO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 6623000.00
MBIO balance_sheet (annual, 2022-12-31) — Construction In Progress: 951000.00
MBIO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 3430000.00
MBIO balance_sheet (annual, 2022-12-31) — Current Assets: 78852000.00
MBIO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 612000.00
MBIO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 612000.00
MBIO balance_sheet (annual, 2022-12-31) — Current Liabilities: 15109000.00
MBIO cash_flow (annual, 2022-12-31) — Depreciation: 3031000.00
MBIO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3031000.00
MBIO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3031000.00
MBIO income_statement (annual, 2022-12-31) — Diluted Average Shares: 137910.00
MBIO income_statement (annual, 2022-12-31) — Diluted EPS: -562.50
MBIO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -77525000.00
MBIO balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 36000.00
MBIO balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 766000.00
MBIO income_statement (annual, 2022-12-31) — EBIT: -74166000.00
MBIO income_statement (annual, 2022-12-31) — EBITDA: -71135000.00
MBIO cash_flow (annual, 2022-12-31) — End Cash Position: 76656000.00
MBIO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 34056000.00
MBIO cash_flow (annual, 2022-12-31) — Free Cash Flow: -68145000.00
MBIO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 255000.00
MBIO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
MBIO income_statement (annual, 2022-12-31) — General And Administrative Expense: 12210000.00
MBIO balance_sheet (annual, 2022-12-31) — Gross PPE: 20710000.00
MBIO income_statement (annual, 2022-12-31) — Interest Expense: 3359000.00
MBIO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 3359000.00
MBIO income_statement (annual, 2022-12-31) — Interest Income: 689000.00
MBIO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 689000.00
MBIO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2710000.00
MBIO balance_sheet (annual, 2022-12-31) — Invested Capital: 73709000.00
MBIO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2952000.00
MBIO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 6623000.00
MBIO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 30000000.00
MBIO balance_sheet (annual, 2022-12-31) — Leases: 7694000.00
MBIO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3334000.00
MBIO balance_sheet (annual, 2022-12-31) — Long Term Debt: 27436000.00
MBIO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 30770000.00
MBIO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 30000000.00
MBIO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
MBIO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 9147000.00
MBIO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 6623000.00
MBIO income_statement (annual, 2022-12-31) — Net Income: -77525000.00
MBIO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -77525000.00
MBIO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -77525000.00
MBIO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -77525000.00
MBIO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -77525000.00
MBIO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -77525000.00
MBIO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -77525000.00
MBIO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -365000.00
MBIO income_statement (annual, 2022-12-31) — Net Interest Income: -2670000.00
MBIO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 30000000.00
MBIO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 30000000.00
MBIO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2670000.00
MBIO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -2773000.00
MBIO balance_sheet (annual, 2022-12-31) — Net PPE: 12309000.00
MBIO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2587000.00
MBIO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 46273000.00
MBIO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 270000.00
MBIO balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 270000.00
MBIO income_statement (annual, 2022-12-31) — Normalized EBITDA: -71135000.00
MBIO income_statement (annual, 2022-12-31) — Normalized Income: -77525000.00
MBIO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -65066000.00
MBIO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 255000.00
MBIO income_statement (annual, 2022-12-31) — Operating Income: -76159000.00
MBIO income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
MBIO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 198361.00
MBIO balance_sheet (annual, 2022-12-31) — Other Current Assets: 2897000.00
MBIO balance_sheet (annual, 2022-12-31) — Other Equity Interest: 1109000.00
MBIO income_statement (annual, 2022-12-31) — Other Gand A: 12210000.00
MBIO income_statement (annual, 2022-12-31) — Other Income Expense: 1304000.00
MBIO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2860000.00
MBIO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1261000.00
MBIO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1304000.00
MBIO income_statement (annual, 2022-12-31) — Other Operating Expenses: -1304000.00
MBIO balance_sheet (annual, 2022-12-31) — Other Properties: 2918000.00
MBIO balance_sheet (annual, 2022-12-31) — Other Receivables: 263000.00
MBIO balance_sheet (annual, 2022-12-31) — Payables: 7599000.00
MBIO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 11029000.00
MBIO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3468000.00
MBIO balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 250000.00
MBIO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
MBIO income_statement (annual, 2022-12-31) — Pretax Income: -77525000.00
MBIO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 206000.00
MBIO balance_sheet (annual, 2022-12-31) — Properties: 0.00
MBIO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -365000.00
MBIO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2714000.00
MBIO balance_sheet (annual, 2022-12-31) — Receivables: 299000.00
MBIO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 3031000.00
MBIO cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
MBIO income_statement (annual, 2022-12-31) — Research And Development: 63949000.00
MBIO balance_sheet (annual, 2022-12-31) — Retained Earnings: -329369000.00
MBIO cash_flow (annual, 2022-12-31) — Sale Of PPE: 127000.00
MBIO income_statement (annual, 2022-12-31) — Selling General And Administration: 12210000.00
MBIO balance_sheet (annual, 2022-12-31) — Share Issued: 198361.00
MBIO income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
MBIO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2283000.00
MBIO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 46273000.00
MBIO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 46273000.00
MBIO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
MBIO balance_sheet (annual, 2022-12-31) — Total Assets: 92422000.00
MBIO balance_sheet (annual, 2022-12-31) — Total Capitalization: 73709000.00
MBIO balance_sheet (annual, 2022-12-31) — Total Debt: 31382000.00
MBIO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 46273000.00
MBIO income_statement (annual, 2022-12-31) — Total Expenses: 76159000.00
MBIO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 46149000.00
MBIO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 13570000.00
MBIO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 31040000.00
MBIO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -76159000.00
MBIO income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
MBIO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MBIO balance_sheet (annual, 2022-12-31) — Working Capital: 63743000.00
MBIO income_statement (annual, 2023-12-31) — +Operating Expense: 50726000.00
MBIO income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
MBIO balance_sheet (annual, 2023-12-31) — Accounts Payable: 6322000.00
MBIO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4476000.00
MBIO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 380502000.00
MBIO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
MBIO balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
MBIO income_statement (annual, 2023-12-31) — Basic Average Shares: 172031.00
MBIO income_statement (annual, 2023-12-31) — Basic EPS: -299.95
MBIO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 76656000.00
MBIO cash_flow (annual, 2023-12-31) — Capital Expenditure: -114000.00
MBIO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2498000.00
MBIO balance_sheet (annual, 2023-12-31) — Capital Stock: 1000.00
MBIO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 6234000.00
MBIO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 6234000.00
MBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -26082000.00
MBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 5886000.00
MBIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -49476000.00
MBIO cash_flow (annual, 2023-12-31) — Change In Account Payable: 192000.00
MBIO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -680000.00
MBIO cash_flow (annual, 2023-12-31) — Change In Payable: 192000.00
MBIO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 192000.00
MBIO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 1092000.00
MBIO cash_flow (annual, 2023-12-31) — Change In Receivables: -3580000.00
MBIO cash_flow (annual, 2023-12-31) — Change In Working Capital: -2976000.00
MBIO cash_flow (annual, 2023-12-31) — Changes In Cash: -69672000.00
MBIO balance_sheet (annual, 2023-12-31) — Common Stock: 1000.00
MBIO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 123000.00
MBIO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 4561000.00
MBIO balance_sheet (annual, 2023-12-31) — Construction In Progress: 29000.00
MBIO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 4857000.00
MBIO balance_sheet (annual, 2023-12-31) — Current Assets: 11346000.00
MBIO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 520000.00
MBIO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 520000.00
MBIO balance_sheet (annual, 2023-12-31) — Current Liabilities: 15371000.00
MBIO cash_flow (annual, 2023-12-31) — Depreciation: 2225000.00
MBIO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2225000.00
MBIO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2225000.00
MBIO income_statement (annual, 2023-12-31) — Diluted Average Shares: 172031.00
MBIO income_statement (annual, 2023-12-31) — Diluted EPS: -299.95
MBIO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -51602000.00
MBIO balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 0.00
MBIO balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 834000.00
MBIO income_statement (annual, 2023-12-31) — EBIT: -50289000.00
MBIO income_statement (annual, 2023-12-31) — EBITDA: -48064000.00
MBIO cash_flow (annual, 2023-12-31) — End Cash Position: 6984000.00
MBIO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -26081000.00
MBIO cash_flow (annual, 2023-12-31) — Free Cash Flow: -49591000.00
MBIO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -1466000.00
MBIO income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 1466000.00
MBIO income_statement (annual, 2023-12-31) — General And Administrative Expense: 9686000.00
MBIO balance_sheet (annual, 2023-12-31) — Gross PPE: 9289000.00
MBIO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
MBIO income_statement (annual, 2023-12-31) — Interest Expense: 1313000.00
MBIO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1313000.00
MBIO income_statement (annual, 2023-12-31) — Interest Income: 850000.00
MBIO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 850000.00
MBIO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1340000.00
MBIO balance_sheet (annual, 2023-12-31) — Invested Capital: 123000.00
MBIO cash_flow (annual, 2023-12-31) — Investing Cash Flow: 5886000.00
MBIO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 4561000.00
MBIO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
MBIO balance_sheet (annual, 2023-12-31) — Leases: 7694000.00
MBIO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1978000.00
MBIO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1978000.00
MBIO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
MBIO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -30375000.00
MBIO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 0.00
MBIO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 4561000.00
MBIO income_statement (annual, 2023-12-31) — Net Income: -51602000.00
MBIO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -51602000.00
MBIO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -51602000.00
MBIO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -51602000.00
MBIO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -51602000.00
MBIO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -51602000.00
MBIO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -51602000.00
MBIO cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -50000.00
MBIO income_statement (annual, 2023-12-31) — Net Interest Income: -463000.00
MBIO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -30375000.00
MBIO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -30375000.00
MBIO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -463000.00
MBIO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -445000.00
MBIO balance_sheet (annual, 2023-12-31) — Net PPE: 4813000.00
MBIO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 5936000.00
MBIO cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -30375000.00
MBIO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 123000.00
MBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 270000.00
MBIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 270000.00
MBIO income_statement (annual, 2023-12-31) — Normalized EBITDA: -46734000.00
MBIO income_statement (annual, 2023-12-31) — Normalized Income: -50272000.00
MBIO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -49477000.00
MBIO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1330000.00
MBIO income_statement (annual, 2023-12-31) — Operating Income: -50726000.00
MBIO income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
MBIO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 1012882.00
MBIO balance_sheet (annual, 2023-12-31) — Other Current Assets: 1233000.00
MBIO balance_sheet (annual, 2023-12-31) — Other Equity Interest: 591000.00
MBIO income_statement (annual, 2023-12-31) — Other Gand A: 9686000.00
MBIO income_statement (annual, 2023-12-31) — Other Income Expense: -413000.00
MBIO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 978000.00
MBIO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1583000.00
MBIO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 917000.00
MBIO balance_sheet (annual, 2023-12-31) — Other Properties: 1566000.00
MBIO balance_sheet (annual, 2023-12-31) — Other Receivables: 3879000.00
MBIO income_statement (annual, 2023-12-31) — Other Special Charges: 2796000.00
MBIO balance_sheet (annual, 2023-12-31) — Payables: 7156000.00
MBIO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 12013000.00
MBIO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2838000.00
MBIO balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 250000.00
MBIO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
MBIO income_statement (annual, 2023-12-31) — Pretax Income: -51602000.00
MBIO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 178000.00
MBIO balance_sheet (annual, 2023-12-31) — Properties: 0.00
MBIO cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -50000.00
MBIO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -64000.00
MBIO balance_sheet (annual, 2023-12-31) — Receivables: 3879000.00
MBIO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2225000.00
MBIO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -30375000.00
MBIO income_statement (annual, 2023-12-31) — Research And Development: 41040000.00
MBIO balance_sheet (annual, 2023-12-31) — Retained Earnings: -380971000.00
MBIO cash_flow (annual, 2023-12-31) — Sale Of PPE: 6000000.00
MBIO income_statement (annual, 2023-12-31) — Selling General And Administration: 9686000.00
MBIO balance_sheet (annual, 2023-12-31) — Share Issued: 1012882.00
MBIO cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -30375000.00
MBIO income_statement (annual, 2023-12-31) — Special Income Charges: -1330000.00
MBIO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 568000.00
MBIO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 123000.00
MBIO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 123000.00
MBIO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
MBIO balance_sheet (annual, 2023-12-31) — Total Assets: 17742000.00
MBIO balance_sheet (annual, 2023-12-31) — Total Capitalization: 123000.00
MBIO balance_sheet (annual, 2023-12-31) — Total Debt: 2498000.00
MBIO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 123000.00
MBIO income_statement (annual, 2023-12-31) — Total Expenses: 50726000.00
MBIO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 17619000.00
MBIO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 6396000.00
MBIO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2248000.00
MBIO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -49260000.00
MBIO income_statement (annual, 2023-12-31) — Total Unusual Items: -1330000.00
MBIO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1330000.00
MBIO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
MBIO balance_sheet (annual, 2023-12-31) — Working Capital: -4025000.00
MBIO income_statement (annual, 2023-12-31) — Write Off: 0.00
MBIO balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -7273000.00
MBIO cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
MBIO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 720911.00
MBIO income_statement (quarterly, 2024-09-30) — Basic EPS: -1.96
MBIO balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 0.00
MBIO balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 442000.00
MBIO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 720911.00
MBIO income_statement (quarterly, 2024-09-30) — Diluted EPS: -1.96
MBIO cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
MBIO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
MBIO income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
MBIO income_statement (quarterly, 2024-09-30) — Interest Expense: 1000.00
MBIO income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 1000.00
MBIO cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 0.00
MBIO balance_sheet (quarterly, 2024-09-30) — Leases: 7694000.00
MBIO cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
MBIO cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
MBIO cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
MBIO cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -149000.00
MBIO cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 0.00
MBIO balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 625000.00
MBIO balance_sheet (quarterly, 2024-09-30) — Other Properties: 92000.00
MBIO balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
MBIO cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
MBIO cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
MBIO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
MBIO income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
MBIO income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MBIO income_statement (quarterly, 2024-09-30) — Write Off: 0.00
MBIO income_statement (annual, 2024-12-31) — +Operating Expense: 12553000.00
MBIO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
MBIO balance_sheet (annual, 2024-12-31) — Accounts Payable: 7464000.00
MBIO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -7323000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -7323000.00
MBIO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 392234000.00
MBIO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 3692000.00
MBIO cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 1043000.00
MBIO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 1165000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 1165000.00
MBIO income_statement (annual, 2024-12-31) — Basic Average Shares: 609696.00
MBIO income_statement (annual, 2024-12-31) — Basic EPS: -38.57
MBIO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 6984000.00
MBIO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 878000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 878000.00
MBIO balance_sheet (annual, 2024-12-31) — Capital Stock: 5000.00
MBIO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 6839000.00
MBIO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 6839000.00
MBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 11265000.00
MBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
MBIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -11410000.00
MBIO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -447000.00
MBIO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -120000.00
MBIO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1242000.00
MBIO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 586000.00
MBIO cash_flow (annual, 2024-12-31) — Change In Receivables: 494000.00
MBIO cash_flow (annual, 2024-12-31) — Change In Working Capital: 1755000.00
MBIO cash_flow (annual, 2024-12-31) — Changes In Cash: -145000.00
MBIO balance_sheet (annual, 2024-12-31) — Common Stock: 5000.00
MBIO balance_sheet (annual, 2024-12-31) — Common Stock Equity: -3873000.00
MBIO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 7694000.00
MBIO balance_sheet (annual, 2024-12-31) — Construction In Progress: 0.00
MBIO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 0.00
MBIO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1929000.00
MBIO balance_sheet (annual, 2024-12-31) — Current Assets: 8606000.00
MBIO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 456000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 456000.00
MBIO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 456000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 456000.00
MBIO balance_sheet (annual, 2024-12-31) — Current Liabilities: 12609000.00
MBIO cash_flow (annual, 2024-12-31) — Depreciation: 823000.00
MBIO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 823000.00
MBIO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 823000.00
MBIO income_statement (annual, 2024-12-31) — Diluted Average Shares: 609696.00
MBIO income_statement (annual, 2024-12-31) — Diluted EPS: -38.57
MBIO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -15752000.00
MBIO balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 2667000.00
MBIO income_statement (annual, 2024-12-31) — EBIT: -12553000.00
MBIO income_statement (annual, 2024-12-31) — EBITDA: -11730000.00
MBIO cash_flow (annual, 2024-12-31) — End Cash Position: 6839000.00
MBIO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 11265000.00
MBIO cash_flow (annual, 2024-12-31) — Free Cash Flow: -11410000.00
MBIO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 29000.00
MBIO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
MBIO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
MBIO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
MBIO income_statement (annual, 2024-12-31) — General And Administrative Expense: 4135000.00
MBIO balance_sheet (annual, 2024-12-31) — Gross PPE: 452000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 452000.00
MBIO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 3692000.00
MBIO income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 1043000.00
MBIO income_statement (annual, 2024-12-31) — Interest Expense: 5000.00
MBIO income_statement (quarterly, 2024-12-31) — Interest Expense: 1000.00
MBIO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 5000.00
MBIO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 1000.00
MBIO income_statement (annual, 2024-12-31) — Interest Income: 179000.00
MBIO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 179000.00
MBIO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
MBIO cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 0.00
MBIO balance_sheet (annual, 2024-12-31) — Invested Capital: -3873000.00
MBIO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
MBIO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 7694000.00
MBIO balance_sheet (annual, 2024-12-31) — Leases: 371000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Leases: 371000.00
MBIO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 422000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 422000.00
MBIO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 422000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 422000.00
MBIO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 7694000.00
MBIO income_statement (annual, 2024-12-31) — Net Income: -15752000.00
MBIO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -15752000.00
MBIO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -15752000.00
MBIO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -15752000.00
MBIO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -15752000.00
MBIO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -15752000.00
MBIO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -15752000.00
MBIO cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
MBIO cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
MBIO income_statement (annual, 2024-12-31) — Net Interest Income: 179000.00
MBIO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
MBIO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
MBIO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 179000.00
MBIO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1455000.00
MBIO cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -626000.00
MBIO balance_sheet (annual, 2024-12-31) — Net PPE: 452000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Net PPE: 452000.00
MBIO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
MBIO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
MBIO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -3873000.00
MBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 150000.00
MBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 150000.00
MBIO income_statement (annual, 2024-12-31) — Normalized EBITDA: -8038000.00
MBIO income_statement (annual, 2024-12-31) — Normalized Income: -12060000.00
MBIO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -11410000.00
MBIO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 29000.00
MBIO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 0.00
MBIO income_statement (annual, 2024-12-31) — Operating Income: -12553000.00
MBIO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
MBIO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1831357.00
MBIO balance_sheet (annual, 2024-12-31) — Other Current Assets: 200000.00
MBIO balance_sheet (annual, 2024-12-31) — Other Equity Interest: 611000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 611000.00
MBIO income_statement (annual, 2024-12-31) — Other Gand A: 4135000.00
MBIO income_statement (annual, 2024-12-31) — Other Income Expense: -3378000.00
MBIO income_statement (quarterly, 2024-12-31) — Other Income Expense: -1043000.00
MBIO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1507000.00
MBIO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 250000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 250000.00
MBIO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 314000.00
MBIO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 0.00
MBIO balance_sheet (annual, 2024-12-31) — Other Properties: 81000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Other Properties: 81000.00
MBIO balance_sheet (annual, 2024-12-31) — Other Receivables: 402000.00
MBIO balance_sheet (annual, 2024-12-31) — Payables: 10131000.00
MBIO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 12060000.00
MBIO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 93000.00
MBIO balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 250000.00
MBIO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
MBIO income_statement (annual, 2024-12-31) — Pretax Income: -15752000.00
MBIO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 3571000.00
MBIO cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 3520000.00
MBIO balance_sheet (annual, 2024-12-31) — Properties: 0.00
MBIO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MBIO cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
MBIO cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: 0.00
MBIO cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
MBIO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
MBIO balance_sheet (annual, 2024-12-31) — Receivables: 402000.00
MBIO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 823000.00
MBIO cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
MBIO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
MBIO income_statement (annual, 2024-12-31) — Research And Development: 8418000.00
MBIO balance_sheet (annual, 2024-12-31) — Retained Earnings: -396723000.00
MBIO cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
MBIO income_statement (annual, 2024-12-31) — Selling General And Administration: 4135000.00
MBIO balance_sheet (annual, 2024-12-31) — Share Issued: 1831357.00
MBIO cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
MBIO income_statement (annual, 2024-12-31) — Special Income Charges: -3692000.00
MBIO income_statement (quarterly, 2024-12-31) — Special Income Charges: -1043000.00
MBIO cash_flow (annual, 2024-12-31) — Stock Based Compensation: -450000.00
MBIO balance_sheet (annual, 2024-12-31) — Stockholders Equity: -3873000.00
MBIO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -3873000.00
MBIO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
MBIO balance_sheet (annual, 2024-12-31) — Total Assets: 9308000.00
MBIO balance_sheet (annual, 2024-12-31) — Total Capitalization: -3873000.00
MBIO balance_sheet (annual, 2024-12-31) — Total Debt: 878000.00
MBIO balance_sheet (quarterly, 2024-12-31) — Total Debt: 878000.00
MBIO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -3873000.00
MBIO income_statement (annual, 2024-12-31) — Total Expenses: 12553000.00
MBIO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 13181000.00
MBIO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 702000.00
MBIO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 572000.00
MBIO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -16245000.00
MBIO income_statement (annual, 2024-12-31) — Total Unusual Items: -3692000.00
MBIO income_statement (quarterly, 2024-12-31) — Total Unusual Items: -1043000.00
MBIO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -3692000.00
MBIO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1043000.00
MBIO balance_sheet (annual, 2024-12-31) — Working Capital: -4003000.00
MBIO income_statement (annual, 2024-12-31) — Write Off: 3692000.00
MBIO income_statement (quarterly, 2024-12-31) — Write Off: 1043000.00
MBIO income_statement (quarterly, 2025-03-31) — +Operating Expense: 253000.00
MBIO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 6309000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 400485000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
MBIO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 2860946.00
MBIO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.05
MBIO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 6839000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 14231000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 14231000.00
MBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 7616000.00
MBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 1165000.00
MBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1389000.00
MBIO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -73000.00
MBIO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -537000.00
MBIO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -11000.00
MBIO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 185000.00
MBIO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -436000.00
MBIO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 7392000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3609000.00
MBIO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 7616000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1868000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Current Assets: 14909000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 11150000.00
MBIO cash_flow (quarterly, 2025-03-31) — Depreciation: 41000.00
MBIO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 41000.00
MBIO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 41000.00
MBIO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 2860946.00
MBIO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.05
MBIO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -153000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 2813000.00
MBIO income_statement (quarterly, 2025-03-31) — EBIT: -253000.00
MBIO income_statement (quarterly, 2025-03-31) — EBITDA: -212000.00
MBIO cash_flow (quarterly, 2025-03-31) — End Cash Position: 14231000.00
MBIO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 7616000.00
MBIO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1389000.00
MBIO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1217000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 0.00
MBIO income_statement (quarterly, 2025-03-31) — Interest Income: 100000.00
MBIO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 100000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3609000.00
MBIO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 1165000.00
MBIO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 7616000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
MBIO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 7616000.00
MBIO income_statement (quarterly, 2025-03-31) — Net Income: -153000.00
MBIO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -153000.00
MBIO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -153000.00
MBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -153000.00
MBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -153000.00
MBIO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -153000.00
MBIO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -153000.00
MBIO income_statement (quarterly, 2025-03-31) — Net Interest Income: 100000.00
MBIO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 100000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Net PPE: 0.00
MBIO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 1165000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3609000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 150000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 150000.00
MBIO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -212000.00
MBIO income_statement (quarterly, 2025-03-31) — Normalized Income: -153000.00
MBIO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1389000.00
MBIO income_statement (quarterly, 2025-03-31) — Operating Income: -253000.00
MBIO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 3373431.00
MBIO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 211000.00
MBIO income_statement (quarterly, 2025-03-31) — Other Gand A: 1217000.00
MBIO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -879000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 467000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Payables: 9122000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 10990000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 160000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 250000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
MBIO income_statement (quarterly, 2025-03-31) — Pretax Income: -153000.00
MBIO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Receivables: 467000.00
MBIO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 41000.00
MBIO income_statement (quarterly, 2025-03-31) — Research And Development: -964000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -396876000.00
MBIO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 1165000.00
MBIO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1217000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Share Issued: 3373431.00
MBIO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 38000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3609000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3609000.00
MBIO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MBIO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Total Assets: 14909000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3609000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Total Debt: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3609000.00
MBIO income_statement (quarterly, 2025-03-31) — Total Expenses: 253000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11300000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 0.00
MBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 150000.00
MBIO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -253000.00
MBIO balance_sheet (quarterly, 2025-03-31) — Working Capital: 3759000.00
MBIO income_statement (quarterly, 2025-06-30) — +Operating Expense: 885000.00
MBIO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5650000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 400530000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4021276.00
MBIO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.19
MBIO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 14231000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 12657000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 12657000.00
MBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -235000.00
MBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
MBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1339000.00
MBIO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
MBIO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -816000.00
MBIO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 39000.00
MBIO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 250000.00
MBIO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -527000.00
MBIO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1574000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2892000.00
MBIO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: -235000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1778000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Current Assets: 13046000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 10004000.00
MBIO cash_flow (quarterly, 2025-06-30) — Depreciation: 0.00
MBIO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 0.00
MBIO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4021276.00
MBIO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.19
MBIO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -762000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 2504000.00
MBIO income_statement (quarterly, 2025-06-30) — EBIT: -885000.00
MBIO income_statement (quarterly, 2025-06-30) — EBITDA: -885000.00
MBIO cash_flow (quarterly, 2025-06-30) — End Cash Position: 12657000.00
MBIO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -235000.00
MBIO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1339000.00
MBIO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 787000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
MBIO income_statement (quarterly, 2025-06-30) — Interest Income: 123000.00
MBIO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 123000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2892000.00
MBIO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
MBIO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: -235000.00
MBIO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 0.00
MBIO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 0.00
MBIO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -235000.00
MBIO income_statement (quarterly, 2025-06-30) — Net Income: -762000.00
MBIO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -762000.00
MBIO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -762000.00